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GENETIC VARIA TON IN THE RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM: 
ASSOCIATIONS WITH BLOOD PRESSRURE DIPPING IN 
THE JACKSON HEART STUDY 
Jersy L. Napoleon 
August 6,2012 
Cardiovascular diseases, including hypertension, are the leading causes of death in 
the United States. African-Americans carry the highest burden of disease with 32% of 
adults with hypertension. Blood pressure (BP) dipping, defined as a drop of> 10% in 
blood pressure from daytime to nighttime, occurs less often in African-Americans and is 
a risk factor for CVD. BP dipping has a significant genetic component. This study 
focuses on the single nucleotide polymorphisms (SNPs) in the renin-angiotensin-
aldosterone system that may influence BP dipping in this population. A total of 928 
participants (266 dippers and 664 non-dippers) from the Jackson Heart Study (JHS) were 
analyzed. The study found that 37 common SNPs across three genes (ACE, AGT, and 
AGTRl) were not significantly associated with BP dipping in this population. Therefore, 
there are likely additional genes and possibly other SNPs within these genes that are 
responsible for the genetic contribution to BP dipping. 
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INTROOUCTION 
Cardiovascular diseases (CVO) are the leading cause of death in the country [lJ. 
The prevalence of CVO is increasing each year and the profile of CVD patients is getting 
younger in age (under 65) [2]. Not only does CVD account for 17% of the national health 
expenditures, but costs are projected to rise 61 % by 2030 [3,4]. In 2008, heart disease 
and strokes accounted for over 470 million dollars in direct and indirect costs [5]. 
In the United States, hypertension or high blood pressure (HBP) is considered one 
of the major risk factors for CVD [6, 7] . Hypertension increases the incidence of 
ischemic and hemorrhagic stroke, coronary heart disease, left ventricular mass and renal 
disease. An individual can acquire either essential (primary) or secondary hypertension. 
Causes of secondary hypertension may be due to prescribed pharmaceuticals or 
complications of other diseases, such as preeclampsia, renal artery stenosis, endocrine 
disorders, and obstructive sleep apnea [8J . However, secondary hypertension accounts 
for a very small percentage of all hypertension cases in the United States. Ninety to nine-
five percent of hypertension cases are primary (or essential) [8]. Major risk factors for 
primary hypertension are age, ethnicity, gender, lack of physical activity, high salt intake, 
obesity, insulin resistance, high alcohol intake, socioeconomic status (SES) and family 
history [7, 8]. 
Primary hypertension is especially a concern in African-Americans because they 
carry a disproportionately higher burden of the disease than other ethnic groups. Unlike 
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other ethnic groups, hypertension is more common and severe in African-Americans. 
African-Americans also have a higher of occurrence of coronary heart disease and are 
also more like to die from CVD than their white counterparts [9]. According to the Center 
for Disease Control and Prevention (CDC), between 2005 and 2008, an estimated 18% of 
US adults 18 years and older in the United States were considered pre-hypertensive, 
while 30% of US adults had hypertension due to a high systolic or diastolic BP. In 
addition, African-Americans are more likely than white Americans to develop 
hypertension (32% vs. 25%) [10]. 
2 
THE BIOLOGY OF HYPERTENSION 
Hypertension is a failure of the body's attempt to normalize blood pressure. Blood 
pressure is mainly regulated by the renin-angiotensin-aldosterone system (RAAS) (Fig. 
1). RAAS is a cascade of enzymatic and hormonal chemical reactions involving the 
kidneys and the sympathetic nervous system [11]. RAAS regulates blood volume, cardiac 
output, vasoconstriction in the body, sodium and water balance. Angiotensinogen, 
released by the liver, interacts with the renal enzyme renin to produce angiotensin I (Ang 
I), which in turn reacts with the angiotensin-converting enzyme (ACE) to produce 
angiotensin II (Ang II) [12, 13]. Angiotensin II, a highly vasoactive peptide, causes 
vasoconstriction in the blood vessels, which increases blood pressure. Angiotensin II 
stimulates the adrenal glands to secrete aldosterone, which increases salt and water 
retention and blood volume, raising the blood pressure [14]. 
RAAS works in a circadian rhythm, which allows blood pressure to naturally 
fluctuate [15]. RAAS activity generally decreases at nighttime and increases again during 
the daytime. However, for some individuals RAAS remains very active during both day 
and night. As a result, the adrenal glands consistently stimulate a release of renin and the 
levels of ACE, angiotensinogen, Ang I, Ang II and aldosterone, remain high [14]. An 
insufficient drop of blood pressure from day to night has been associated with CVD [11, 
14,16,17]. 
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HYPERTENSION AND RAAS GENES 
Studies have shown that hypertension may be a multi-factorial disease where 
there is an interaction between environmental and genetic factors [7]. The 
angiotensinogen (AGT), angiotensin II type I-receptor AGTRl (also called ATR1,) and 
the angiotensin I-converting-enzyme (ACE) genes in chromosomes 1,3, and 17 
respectively, are three genes that have been associated with hypertension and RAAS [18-
20]. 
The CORGENE study, which compared coronary atherosclerosis in 156 
Caucasians with post-myocardial infarctions (MI) and 307 healthy patients with no 
history ofMI, was one of the firsts to report association with anAGTpolymorphism. The 
study found thatAGTM235T, located in chromosome 1 position 235, where there is a 
methionine to threonine substitution, was associated with hypertension [21]. Likewise, in 
a cohort study of916 black and 771 white post-myocardial infarction patients, 
Goldenberg and company found that the M235T polymorphism in the AGT gene was 
associated with increased levels of angiotensinogen and high blood pressure. The 
frequency of the T allele was substantially more common in black patients (82%) then in 
white (44%) patients. Black patients with essential hypertension who were homozygous 
for the T allele (TT) were over 3 times more likely to experience a cardiac event [22]. 
Moreover, a meta-analysis of 11 studies published between 1992 and 1996, including 14 
different populations with 5,493 individuals, reported that the AGTM235T 
polymorphism was significantly associated with hypertension (Odds Ratio (OR): 1.20; 
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95% Confidence Interval (CI): 1.11-1.29; (P-value) P<.0001) and the association 
increased with a family history of hypertension (OR: 1.42; 95% CI: 1.25 -1.61, P<.0001) 
[23]. 
The AGTRI gene has also been linked to essential hypertension in different 
populations. Five genetic variants ofthe AGTRI gene were found in 239 hypertensive 
and 371 normotensive Mexican individuals [24]. However, the study found that 
participants who had rs5182 CC genotype were more at risk of hypertension (OR=1.83, 
p=0.009). A recent meta-analysis, which examined 24 different populations in 22 case-
control studies published through February 2010 and included 8,249 hypertensive 
individuals and 8,225 controls, reported thatAGTRl +1166 C allele was associated with 
essential hypertension (OR:1.14; 95%CI, 1.00-1.30; P=0.05) [25]. 
Finally, the Framingham Heart Study reported an association between common 
variants of the ACE gene and essential hypertension and high levels of angiotensinogen 
[26]. The study looked at 276 men and 333 women with hypertension and found that men 
with the ACE DD allele were at a higher risk of developing hypertension than women. 
5 
HYPERTENSION AND RASS GENES IN AFRICAN-AMERICANS 
Fewer studies of genes associated with hypertension have specifically targeted 
African-Americans compared to their white counterparts. However, studies like the 
International Collaborative Study on Hypertension (ICSHIB) examined the relationship 
between hypertension and environment in African descendants by comparing seven 
populations representing Nigeria, rural and urban areas of Cameroon, St. Lucia, 
Barbados, Jamaica and Chicago, Illinois. The study found an increase in prevalence of 
hypertension in participants who lived in urban (19.1 %) and rural areas (15.1 %) of 
Cameroon. Despite the variation of hypertension in West Africa, the results concluded 
that as the geographical region moved from east to west there was an increase in 
hypertension, with Nigeria having the lowest prevalence at 14.5% versus the US at 32.6% 
[27]. The same pattern was observed when the participants were stratified by gender: US 
males and females were more likely to be hypertensive than West Africans and 
Caribbean blacks, with US females displaying the highest prevalence over all [27]. 
Adeyemo and colleagues conducted a genome wide association study (GW AS) 
of hypertension in over 1,000 African-Americans residing in Washington, DC. They 
examined 800,000 single nucleotide polymorphisms (SNPs). The study found that (SNPs) 
were associated with biological systems and networks important to the regulation of 
blood pressure. Single nucleotide polymorphisms, such as PMS1, SLC24A4, YWHA7, 
IP07, and CACANAIH were specifically found to be associated with systolic blood 
pressure [28]. 
6 
BLOOD PRESSURE DIPPING 
Accumulating evidence indicates that a decline in nocturnal blood pressure 
relative to daytime blood pressure, also known as blood pressure (BP) dipping, is an 
independent predictor of hypertension. BP dipping is defined as having a change of 10% 
or more in blood pressure from awake to sleeping hours [29]. In a study of blood 
pressure heritability in European-American and African-American twins, Wang et al. 
suggested that there may be distinct genes that influence nocturnal vs. diurnal blood 
pressure [30]. 
In the Wisconsin Sleep Cohort Study, investigators examined the influence of 
specific genetic variants on BP dipping in 497 non-hypertensive European Americans 
ages 30-60 years, not on hypertensive medication [16]. Blood pressure dipping was 
defined as having a 10% or greater change in blood pressure from daytime to nighttime. 
Single nucleotide polymorphisms (SNPs) in two types of beta-adrenergic receptors (~1-
AR and ~2-AR) were examined. These adrenergic receptors, which are proteins 
associated with the sympathetic nervous system, control the heart rate, and cardiac 
contractility, and conduction of cardiac muscle [31] . ~2-AR, specifically, is involved in 
the release of renin. Renin affects blood pressure by stimulating the release of aldosterone 
in the body [14, 16]. This study found that beta-adrenergic receptors particularly affect 
nighttime BP, which is the blood pressure mostly associated to BP dipping [11, 16]. The 
study found that ~2-AR rs2400707 was statistically significant with systolic (SBP) and 
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diastolic (DBP) blood pressure dipping. Those who were homozygous for AlA 
haplotypes were more likely to display a non-dipping pattern (less than 10% BP dipping) 
than those with AlG haplotypes (OR: 2.0; 95% CI, 1.0-3.8 vs. OR: 1.6; 95% CI, 0.9-2.8; 
P=0.04) [16]. 
Julve and colleagues reported an association between BP dipping and the 
insertion and deletion polymorphisms of the ACE gene in a sample of99 previously-
untreated hypertensive Caucasians less than 50 years old. The study analyzed three ACE 
gene genotypes (IL ID, and DD) and discovered that those who were homozygous for the 
D allele had less nocturnal fall of SBP than the other genotypes [32]. Only two other 
studies have shown that there is an association between BP dipping and the D alleles of 
the A CE gene. One study reported that parents of 65 Chinese hypertensives who had the 
D allele had a higher average 24-hr BP and a higher nocturnal BP [33]. In the other study, 
235 untreated elderly Japanese hypertensives with the D allele had higher nighttime BP 
[16,34]. 
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BLOOD PRESSURE DIPPING IN AFRICAN-AMERICANS 
Most of the studies on BP dipping in African-Americans have focused mainly on 
the social and environmental factors affecting BP dipping. Hickson and colleagues 
explored the association between BP dipping and socioeconomic position (SEP), such as 
income and education, in the 837 eligible African-Americans in the Jackson Heart Study. 
Although the study concluded that a higher SEP was related to a greater BP dipping, the 
study also discovered that the prevalence of dippers was slightly higher in men than 
women (33% and 32%, respectively); the dippers were younger (57.4 vs. 60.1 years), had 
a lower BMI (30 vs. 31), consumed considerably more alcohol (6.1 vs. 2.5 grams/day), 
were less likely to be diabetic (16 vs. 22%) and to have CVD (6.4 to 11%) [35]. 
Barksdale and colleagues investigated the effects of stress on BP dipping in thirty 
non-hypertensive African-American women ages 26 to 51 years [36]. Ambulatory blood 
pressure monitoring (ABPM), the most common technique used to determine BP dipping 
status of individuals was performed and collected in the participants' homes. 
Ambulatory blood pressure monitoring measures blood pressure variation during the 
normal, daily routines of the individuals and it's considered more accurate than BP 
clinical readings Stress was assessed using a questionnaire that evaluated the participant's 
psychosocial factors (i.e. perceived stress and daily hassles) and personal factors (i.e. age, 
income, BMI). Using the same definition ofBP dipping as the aforementioned research 
[16,32,35], the study observed that about 30% of the participants were non-dippers. 
However, there was no significant association between the psychosocial and personal 
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factors and BP dipping in this population [36]. Similarly, Sherwood and colleagues 
investigated the associations between psychosocial and lifestyle factors and BP dipping, 
including sleep quality, in 56 African-Americans and 72 white Americans [17]. African-
Americans were more likely to have a higher awake and sleep SBP and DBP and were 
less likely to be a dipper. Compared to white participants, African-Americans were also 
younger, had a higher BMI, a poorer sleep quality, and were at a higher risk of 
developing diabetes. There are other studies that have confirmed the influence of certain 
environmental factors on BP dipping [37, 38]; however, relatively little research to date 
has been directed at identifying genetic factors associated with BP dipping in African-
Americans. This MS thesis will examine the influence of AGT, AGTR1, and ACE on BP 





Mississippi's population is just under 3 million [39]. The state's burden of 
diseases is among the highest in the nation. Of the total deaths in Mississippi, twenty-
eight percent are due to heart disease [40]. According to a Vital Statistics report by the 
National Center for Health Statistics, hypertension in Mississippi is currently the highest 
in the nation at about 34 percent, which is approximately 700,000 individuals [40]; and 
African-Americans, who comprise 37% of the population in Mississippi, also carry the 
highest burden of disease in the state [39]. 
RECRUITMENT 
The Jackson Heart Study is a community-based cohort study of African-
Americans residing in Jackson, Mississippi [41]. The original study recruited 5,302 
African-American men and women between the ages of21 and 92 [42]. The JHS was a 
derivative of the Atherosclerosis Risk in Communities study CARIC). The JHS was 
specifically designed to illuminate risk factors for CVD morbidity and mortality among 
African-Americans residing in Mississippi [43]. Eligible African-Americans from ARIC 
and the nearby community were recruited by random selection [41-43]. They were 
recruited from the three counties surrounding Jackson, Mississippi: Hinds, Madison, and 
Rankin. To determine the BP dipping status ofthis population, all the JHS participants 
were encouraged to participate in 24-hr ambulatory BP monitoring CAB PM), but data 
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collection was complete for only 1,150 participants [35]. The ABPM method eliminates 
the "white-coat effect", which is the natural anxiety that occurs in patients when they are 
seen by healthcare providers in a clinical setting, by performing the readings in the 
comfort ofthe homes of each participant [42]. In this study, the JHS participants were 
taught to use the ABPM device by trained technicians to self-measure their daily BP 
every 20 minutes during the sleep (6:01AM to 5:59 PM) and awake (6 AM to 6 PM) 
hours. 
STATISTICAL ANALYSES 
Statistical power for the analyses was based on the available data for 1,150 
participants with APBM in the JHS. The power calculations assumed an additive genetic 
model with the minor allele frequency varying from 0.05 to 0.45, an alpha of 0.05, 0.005 
and 0.0005 and 80% power. This thesis chose the additive genetic model over the 
recessive or dominant models because it's working under the assumption that SNPs are 
neither recessive nor dominant. In addition, the sample size of this study was 
considerably small. So in an effort to capture all possible associations, individuals who 
were heterozygous and homozygous for particular SNP alleles were included in the 
study. This study assumed that each SNP allele contributed differently and that their 
effect on the outcome was in a dosage-type pattern as they increased from 0, 1, and 2. 
The Jackson Heart Study provided data for 1,150 participants who underwent 
ABPM. However, only 930 participants met the criteria, which were a minimum of 54 of 
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72 total BP readings, at least one BP reading per hour, and complete diary 
information of the awake and sleep of hours [35]. Of the 930 participants, two 
participants were excluded due to extreme BP readings, leaving a starting sample of 928 
participants. There were 266 dipper participants with a 10% or more change in blood 
pressure and 662 non-dippers having less than 10% but greater than 0% change in blood 
pressure (Fig. 2). 
Not all of the participants labeled dipper and non-dippers had their genetic data 
available. A total of 724 had complete genotyped SNPs. In the linear regression model, 
645 to 700 participants were analyzed, while in the logistic regression model, between 
645 and 700 participants were observed in the model (Fig. 2). 
With an initial sample size of 266 dippers and 662 non-dippers, an odds ratio of 
1.4 for a minor allele of 0.35 could be consider statistically significant. As the minor 
allele frequency (MAP) decreased, the detectable odds ratio increased (for MAF=0.25, 
the detectable OR=1.5; for MAF=0.15, the detectable OR = 1.6). Power curves for 
logistic regression were generated taking multiple comparisons into account by varying 
the alpha from 0.05, 0.005 and 0.0005 (assuming 1, 10 and 100 independent tests, 
respectively). At a conservative alpha of 0.0005 there was 80% power to detect an odds 
ratio of 1.5 with a minor allele frequency of 0.35. However, the power was greatly 
reduced for SNPs with lower minor allele frequencies (MAF<0.15) (Fig. 3a-3c). The 
power curves for the difference in nighttime mean systolic BP compared to daytime mean 
systolic BP were also adequate powered. An effect size of 0.04 and a MAF of 0.05 could 
be detected at 80% power (Fig. 4). 
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Blood pressure dipping was calculated as a percent difference: mean daytime BP 
minus the mean nighttime BP divided by the mean nighttime BP times 100, In most 
studies blood pressure dipping was defined as the difference of at least 10% [35,44]. 
However, in the Jackson Heart Study the participants' BP dipping status was divided into 
four categories: dippers, non-dippers, ex-dippers, and risers. The dippers were defined as 
having ~20% BP dip; ex-dippers were greater than 10% but less than 20%; non-dippers 
were greater than 0% but less than 10%: and risers were :s 0%. For the purposes of this 
study, the ex-dippers and the risers were grouped along with the non-dippers, making the 
sample size of non-dippers considerably larger than that of the dippers. 
Affymetrix 6.0, a genome-wide human SNP array, was used to determine the 
SNPs in the AGT, ACE, and AGTRl genes. A total of 112 potential SNPs were identified 
in the array. Imputed data, a list of polymorphisms in high linkage disequilibrium or 
linked together in the same gene, were not included in the data analysis because the 
Jackson Heart Study did not have imputed SNP data readily available. Oft he 112 SNPs, 
only 40 SNPs were identified in JHS population. This list was further pruned to a 
shorter, non-redundant list of linkage disequilibrium-tagging SNPs (R2<0.80) using 
Haplo View, a tool used to analyze and visually interpret haplotypes [45] (Fig. 5a-5c). 
Linkage-disequilibrium-tagging SNPs are SNPs that have a high correlation (R2<0.80) 
with other SNPs in the same gene. As a result, LD-tagging allows for only one of the 
SNPs to be represented in the data decreasing multiple comparisons testing and 
increasing the strength of the p-value in the data. Three of the 40 SNPs were dropped due 
to their high LD. Thus, an initial 37 SNPs were tested for association with BP dipping 
(Table 4a-4c). 
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In addition, the SNP annotation proxy (SNAP) online database was used to find 
any non-synonymous, functional proxy SNPs with an MAF of 0.05 in LD with the typed 
SNPs in the JHS population. SNAP uses published SNP data from the International 
HapMap Project, which is a consortium of published scientific information of genes and 
SNPs. SNAP has a search engine in which the desirable SNPs in the AGT, AGTR1, and 
A CE genes to identify proxy SNPs [46]. Since this study was a candidate gene study with 
a small sample size, the GWAS Catalog was used to determine if there were any genome-
wide association studies available out there that had investigated the AGT, AGTR1, or the 
ACE genes [47]. The GWAS catalog, which contains studies that use an agnostic 
approach in choosing SNPs to study versus a candidate gene study, which targets specific 
genes and SNPs based on prior hypotheses, is an online resource of genome-wide 
association studies available to the public. The studies are found by simply going to web 
server and typing the gene, SNP, chromosomal region, type of disease, or title of journal 
article and searching through their database. No studies were found in the GWAS 
catalog. 
Finally, the LocusZoom examined the relationship between the locus, LD, and p-
values of SNPs in reference to each other. Lastly, HapMap uses several populations to 
study polymorphism. Because this analysis focuses on African-Americans, the HapMap 
black population, the Yoruba of Ibadan (YRI), was used in HaploView, SNAP, and 
LocusZoom to collect genetic data. 
All the descriptive statistics were obtained using SAS 9.3. Blood pressure dipping 
was treated both as a continuous and dichotomous variables (linear and logistic 
regression, respectively). Binary variables (dipper vs. non-dipper) were used in the 
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logistic regression analyses and the difference between daytime SBP and nighttime SBP 
was used in the linear model. The models were additive, which tested the association of 
the SNP on BP dipping based on a dosage-type pattern ranging from the presence of 0, 1, 
or 2 effect alleles. All the models were formulated on the likelihood that if the odds ratio 
is greater than one, then the individual is a non-dipper. 
Simple (unadjusted) and multivariable (adjusted) models were tested to 
determine the relationship between the covariates and the outcome. The simple 
comparison models included only the SNP, while the multi variable models included the 
SNPs, the statistically significant covariates and ten principal components (PCs). The 
principal components were previously calculated and provided by the Jackson Heart 
Study. The PCs are used to decrease correlation between certain variables, such as those 
pertaining to ancestry and population substructure in African-Americans, which are 
caused by geographical isolation, genetic drift, or natural selection [48]. Principal 
components were used in this data to adjust the data and to eliminate any potential 
confounding due to the genetic variability within different African-American populations. 
The other covariates and potential confounders associated with BP dipping were 
age, gender, hypertension, hypertension medication, smoking, alcohol consumption, and 
education. Smoking was categorized as non-smoker, previous smoker, and current 
smoker. Alcohol consumption was given as the percent of drinkers. Education was 
classified as less than high school «12yrs), high school graduate (=12yrs) and some 
college or college graduate (>12yrs).T-tests were used to compare dippers and non-
dippers for the continuous variables, while the chi-square (x:) was used to compare 
groups for the categorical variables. The values of the t-tests were expressed in mean ± 
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SD, while the chi-square tests were in percentages (%). A p-value of 0.05 was the cut-off 
for statistical significance for all the tests. 
The linear and logistic models were adjusted for the covariates that were 
statistically significant in this population or for covariates, such as age and gender, which 
were chosen a priori. The logistic regression model was adjusted for age, gender, BMI, 
alcohol consumption, hypertension medication status, and ten principal components. The 




Blood pressure data was collected from 1,150 JHS participants. However, 220 
participants did not have their BP dipping status available due to missing data. Two other 
participants, who were extreme outliers, were excluded from the sample, making 928 
participants the total starting sample size. 
The total female dippers and non-dippers were 181 vs. 460. The total male dippers 
and non-dippers were 85 vs. 202. Gender was not statistically significant (p =0.67). 
However, the rest of the data was reported based on the percent of females because they 
were the majority. Thus, seventy-three percent of female dippers were 65 yrs or younger 
compared to non-dippers at 65% (p=0.004). The dippers tended to have a lower mean 
daytime SBP (dipper: 129.9 ±13.5 vs. non-dipper: 130.4 ±13.8; p=0.59) and mean 
nighttime SBP (dipper: 120.2 ± 13.1 vs. non-dipper: 127.40 ±15.2; p<O.OOOl). 
Non-dippers were more likely to have hypertension (165, 63% vs. 465, 71 %; 
p=0.02), have higher a mean BMI (31.40 ± 6.55 vs. 30AO± 6.14; p=0.04), be on 
hypertension medication (138,57% vs. 403, 64%; p=0.04), and have higher levels of 
aldosterone (5.65, ± 4.7 vs.: 6.2 ± 6.0; p=O.l5) and renin (5.17±34.20 vs. 5.65± 23.70; 
p=0.81). Non-dippers were also more likely to be non-smokers (173, 65 % vs. 452, 68%; 
p=0.42), and to consume less alcohol (139, 52% vs. 265 40%; p=0.0007), and to have 
less college education (dipper: 181,68% vs. 412, 62%; p=0.21) than dippers (Table 1). 
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The population displayed a normal distribution of daytime, systolic blood pressures 
nighttime systolic blood pressure, and the difference between the two (Fig.6a-6c). 
Because the difference between nighttime and daytime blood pressure was normally 
distributed, linear regression could be used to model the effect of each SNP on (daytime-
nighttime blood pressure). In the linear regression model, the AGTRI rs12721234 G 
allele demonstrated the most negative association (~= -1.52±1.10: 95% CI; -3.68-0.64,) 
between the difference in BP dipping; AGTRI rs12721267 G allele demonstrated the 
most positive association (~= 0.90 ±1.12: 95% CI; -1.29-3.10) (Table 3a-3f). However, 
the p-values were not statistically significant (p=0.17 and p=O.l 0, respectively). 
Moreover, because none of the results for any of the SNPs were significant, no 
associations between the SNPs and BP dipping could be established. In fact, none of the 
SNPs showed any association to BP dipping in either the unadjusted or adjusted linear 
regression models. 
In the logistic regression model, the unadjusted results indicated that the AGTRI 
rs12695891 A allele, observed in 569 participants, had an inverse odd ratios (0.70, 95% 
CI; 0.40- 1.23) with a p-value of 0.22. In this model, having an odds ratio less than 1.0 
means that participants with the AGTRI rs12695891 A allele are less likely to be non-
dippers than those without the allele. Similar to the linear regression models, none of the 
SNPs were statistically significantly associated with BP dipping in either the unadjusted 
and adjusted logistic regression models (Table 2a-2f). 
According to SNAP, in the AGT gene, nonsynonymous SNP rs4762 (MAF=0.178) 
was in weak LD (R2=0.3 in YRI) with SNP rsll122577, genotyped in this study. The 
weak link between these two SNPs suggested that there is a small possibility that neither 
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of these SNP affect the BP dipping. In the ACE gene, nonsynonymous SNP rs4303 
(MAF=O.069) was in perfect LD (R2=1.0) with rs4297 (genotyped in this study). The 
SNP rs4303 and was also in strong LD (R2=O.8) with rs1270926 (genotyped in this 
study), so SNP rs4303 s most probably has no association with BP dipping. 
Nonsynonymous SNP rs4364 (MAF=O.077) was in weak LD (R2=O.125) with rs4329 
(genotyped in this study), so the affect ofrs4364 on the outcome is inconclusive. There 
were no nonsynonymous functional SNPs found in the AGTRI genes, so SNAP was not 
utilized to find any proxy SNPs. In addition, the LocusZoom regional plots did not offer 
any addition insight to the association between SNPs and the outcome (Fig. 7a-7c). 
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DISCUSSION 
To our knowledge, this study is the first to examine genes in the renin-angiotensin-
aldosterone system and the association of genetic polymorphisms in BP dipping in 
African-Americans. None of the SNPs tested was significantly associated with BP 
dipping in this population of African-Americans. Although aldosterone (p=O.15) and 
renin (p=O.81) playa vital role in RAAS regulation in blood pressure, neither of them, 
was associated with BP dipping in our data (Table 1). 
This population was well educated with more than two thirds of dippers and non-
dippers having at least some college education. Both groups were overwhelmingly non-
smokers or previous smokers. However, gender, smoking status and education were not 
significantly associated with BP dipping. Nonetheless, as prior studies have noted, other 
traditional risk factors for hypertension were significantly associated with BP dipping 
(age, BMI, and alcohol). Individuals who were dippers tended to be younger, have a 
lower BMI, and consume more alcohol. 
This study was able to survey several SNPs across the three candidate genes, allowing 
for the identification of several types of SNPs (non-synonymous, functional, intronic, or 
near 5' of the gene) (Table 4). Consistent with the literature, this study found that blood 
pressure dipping is highly correlated with both SBP and DBP. However, blood pressure 
dipping was only correlated with nighttime SBP and DBP, while daytime blood pressures 
had no association with the outcome. 
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The variance inflation factors for all adjusted models indicated that multicollinearity 
among the covariates was not a problem. Furthermore, using the ABPM technique to 
collect multiple BP readings of daytime and nighttime systolic and diastolic BP allowed 
for accuracy in the determination of BP dipping status in this population. Additionally, 
having principal components available to adjust for in the data may have decreased 
potential confounders associated with ancestry and admixture within this African-
American population. 
This study did not correct for multiple SNPs tested. Since no association was found 
between SNPs and BP dipping in this population, methods to correct for multiple 
comparisons like Bonferroni correction were not necessary. However, even ifthe results 
had shown any associations between the predictors and the outcome, correcting for 
multiple corrections may have still been inappropriate. Though multiple corrections may 
prevent Type 1 errors, given the high a priori evidence for these genes and their 
dependence among SNPs other more lenient methods would have had to be explored. 
Although none of the SNPs displayed any significant associations with BP dipping 
there are some limitations to this study that should be taken into consideration. There 
was sufficient power to detect an effect size but the sample size was small. From the 
small sample size available, there were participants that had missing data, decreasing the 
sample sometimes to half its size. Also, not all the possible SNPs were analyzed because 
the imputed data were not available for this analysis. In addition, most of the SNPs 
analyzed were not functional. 
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This study was also limited in the ability to generalize its results. As previously 
stated, African-Americans are particularly affected by hypertension compared to whites 
or Hispanics. Although, only white Americans and different SNPs were examined, the 
most similar study to this investigation, the Wisconsin Sleep Study, evaluated 
normotensive participants to determine SNP involvement with BP dipping [16]. 
However, the majority of this population, whether they were labeled dipper or non-
dipper, were hypertensive or on antihypertensive medication. Observing a population of 
African-Americans with neither hypertension nor taking hypertension medication might a 
better way of measuring the genetic effects on BP dipping. In any case, the results of this 
thesis could mainly benefit African-Americans living in other communities similar to the 




To our knowledge, this is the first analysis done on the effect of SNPs in the A GT, 
AGTRJ, and ACE genes in a population of only African-Americans. Although no 
associations were captured in this analysis, one cannot rule out the possibility of other 
factors, beyond this study, interacting with genes and BP dipping. Only common variants 
were analyzed in this study. In future studies, rare variants should also be included 
because it allows for a better survey of genetic variants across the gene. In addition, gene-
environment interactions and other types of genetic of variations, such as deletions, 
insertions, and copy number variants should be taken into consideration. These variants 
might also affect blood pressure dipping. Moreover, a larger sample size, of perhaps 
different races and ethnicities should be included in further studies to increase the ability 
to generalize results across different populations. In conclusion, hypertension is a major 
health problem in African-American communities. Further investigation in this 
population will be needed to determine if genetic factors are involved in the lack of BP 
dipping in African-Americans. 
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Figure 1. The Renin- Angiotensin-Aldosterone System 
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Figure 3a. Power to Detect Effect Size in logistic 
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Figure 3b. Power to Detect Effect Size in logistic 
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Figure 3c. Power to Detect Effect Size in logistic 








1.1 1.2 1.3 1.4 1.5 1.6 1.7 
















Figure 4. Power:Difference in day time-
nighttime mean systolic Blood Pressure 











Figure Sa. Haplotype Map displaying the varying linkage-disequilibrium of SNPs in AGT 
gene. 
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Figure 5c. Haplotype Map displaying the varying linkage-disequilibrium of SNPs in ACE 
gene. 
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Figure 6a. Distribution of mean daytime systolic blood pressure. 
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Figure 6b. Distributions of mean nighttime systolic blood pressure. 
E 
a> 














o I ,~ [b 
,j 
94 90 9 6 102 1 09 114 1 20 126 1 32 1 3 9 144 15 0 156 162 169 174 190 186 192 198 
nightSBP _mean 
33 
Figure 6c. Distribution of difference in mean daytime-nighttime systolic blood pressure. 
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Figure 7a. The association between linkage disequilibrium, recombination rate, and 
statistical significance of SNPs in A GT. 
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Figure 7b. The association between linkage disequilibrium, recombination rate, and 
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Figure 7c. The association between linkage disequilibrium, recombination rate, and 
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Table L Characteristics of blood pressure dippers and nondlppers in the Jackson Heart Study (N=930) 
Dipper Nondipper P-value8 
(N=266) (N=662) 
Age 
1 (21-44) 41 (15%) 70 (11") 0.004 
2 (45-54) 66 (25 %) 134 (20%) 
3(5~) 87 (33%) 226 (34%) 
4(65-74) 65 (24%) 176 (27%) 
5 (7S-84) 7 (3%) 56 (8%) 
Gender (% female) 181 (68%) 460 (69%) 0.67 
Aldosterone (man, SO) 5.65 (4.7) 6.2 (6.0) 0.15 
Rentn (mean, SD) 5. 17 (34.2) 5.65 (23.7) 0.81 
Mean daytime S8P (man, SO) 129.9 (13.5) 130.4 (13.8) 059 
Mean nighttime SBP (mean, SD) 120.2 (13.1) 127.2 (15.2) <.0001 
Mean daytime DBP (mean, SO) 79.9 (9.2) 79.0 (9.4) 0.17 
Mean nighttime DBP (mean, SD, 70.1 (8.9) 73.1 ( 9.7) <.0001 
8MI (mean, SO) 30.4 (6.1 ) 31.4 (6.6) 0.04 
Hypertension (%) 165 (63%) 465 (71%) 0.02 
Hypertension medication (") 138 (57%) 403 (64%) 0.04 
Smoking Status (%) 0.42 
Nonsmoker 173 (65%) 450 (68%) 
Previous smoker 61 (23%) 150 (23%) 
Current smoker 32 (12%) 61 (9%) 
Alcohol consumption (% drinkers) 139 (52%) 265 (40%) 0.0007 
Education "') 0.21 
less than high school «12yrs) 47 (18%) 141 (21%) 
HIP school paduate (=12yrs) 38 (14%) 111 (17%) 
Some college or college graduate(>12yrs) 181 (68%) 410 (62%) 
~ artesortcaI v.nables, - Chi-square test was used; for continuous, _ t-test was used. 
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Table 2-a. Associations of A GT polymorphisms with odds of blood pressure dipping. 
SNP Effect Allele N Odds ratio 95%CI P-value 
rs1926723 C 593 0.88 0040 1.90 0.74 
rs2493129 A 593 0.98 0.60 1.63 0.93 
rsll122576 C 593 1.15 0.57 2.34 0.70 
rs11568026 G 593 1.20 0.82 1.75 0.35 
rs] 1122577 A 592 1.36 0.90 2.04 0.15 
rsll122578 A 593 1.15 0.57 2.34 0.70 
Table 2-b. Associations of ACE olymo hisms with odds of blood pressure dil! in • 
SNP Effect Allele N Odds ratio 95%CI P-value 
rs4297 C 591 1.00 0.64 1.57 0.99 
rs12709426 G 588 1.07 0.63 1.79 0.81 
rs4324 G 590 0.97 0.75 1.25 0.80 
rs4325 A 593 0.87 0.61 1.24 0.44 
rs4329 G 593 0.97 0.75 1.25 0.81 
rs4351 G 586 1.01 0.79 1.31 0.92 
39 
Table 2-c. Associations of AGTRl (!olrmor(!hisms with odds of blood (!ressure di(!(!ing. 
SNP Effect Allele N Odds ratio 95%CI P-value 
rs27565I A 579 1.10 0.82 1.48 0.52 
rs275652 G 592 1.18 0.87 1.60 0.28 
rs12721267 G 593 0.86 0.48 1.54 0.61 
rs2933249 A 593 0.87 0.50 1.50 0.60 
rs12721286 T 591 1.26 0.74 2.12 0.40 
rs12721221 C 585 0.97 0.71 1.33 0.84 
rs2131127 G 592 1.00 0.76 1.31 0.99 
rs12695877 T 592 0.98 0.75 1.27 0.87 
rs4681440 C 593 1.06 0.80 1.41 0.68 
rs12721255 T 593 0.97 0.72 1.31 0.85 
rs4681443 G 592 1.04 0.80 1.34 0.78 
rs4681444 A 593 1.12 0.84 1.49 0.44 
rs1492103 G 593 0.92 0.69 1.22 0.55 
rs1492100 T 592 0.97 0.74 1.26 0.80 
rs3772616 C 592 1.03 0.80 1.33 0.80 
rs4524238 G 592 0.93 0.70 1.23 0.60 
rs12695891 A 586 0.77 0.45 1.31 0.33 
rs12721328 G 593 0.88 0.50 1.57 0.68 
rs1826361 C 593 0.86 0.66 1.12 0.26 
rs12695902 G 593 1.58 0.95 2.62 0.08 
rs12721234 T 583 1.06 0.55 2.06 0.87 
rsl2695918 C 593 0.97 0.68 1.38 0.85 
rs1800766 C 593 0.80 0.54 1.18 0.26 
rs12695923 C 592 1.00 0.75 1.33 1.00 
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Table 2-d. Adjusted associations of A GT polymorphisms with odds of blood 
(!ressure di(!(!ing. 
SNP Effect Allele N Odds ratio 95%CI P-value8 
rs1926723 C 575 1.03 0.46 2.34 0.93 
rs2493129 A 575 1.00 0.60 1.70 1.00 
rs11122576 C 575 1.15 0.54 2.47 0.71 
rs11568026 G 575 1.18 0.80 1.75 0.41 
rs11122577 A 574 1.48 0.95 2.30 0.08 
rs11122578 A 575 1.15 0.54 2.47 0.71 
8 Adjusted for age, gender, BMI, alcohol consumption, hypertension, hypertension 
medication and (!rincipal com(!onents. 
Table 2-e. Adjusted associations of ACE polymorphisms with odds of blood pressure 
di(!(!ing. 
SNP Effect Allele N Odds ratio 95%CI P-value8 
rs4297 C 573 0.97 0.62 1.59 0.96 
rs12709426 G 572 1.01 0.58 1.76 0.96 
rs4324 G 572 0.93 0.71 1.21 0.57 
rs4325 A 575 0.79 0.53 1.17 0.24 
rs4329 G 575 0.93 0.71 1.03 0.59 
rs4351 G 568 1.07 0.82 1.40 0.63 
8 Adjusted for age, gender, BMI, alcohol consumption, hypertension, hypertension 
medication and (!rinci(!al com(!onents. 
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Table 2-f. Adjusted associations ofAGTRl polymorphisms with odds of blood 
~ressure di~~ing. 
SNP Effect N Odds ratio 95%CI p-
Allele value 
rs275651 A 562 1. 12 0.82 1.53 0.48 
rs275652 G 574 1.17 0.85 1.61 0.33 
rs12721267 G 575 0.86 0.47 1.57 0.62 
rs2933249 A 575 0.87 0.48 1.60 0.65 
rs12721286 T 573 1.24 0.72 2.13 0.44 
rs12721221 C 567 0.92 0.66 1.32 0.68 
rs2131127 G 574 1.03 0.77 1.38 0.85 
rs12695877 T 575 1.02 0.76 1.36 0.90 
rs4681440 C 575 1.16 0.85 1.58 0.36 
rs12721255 T 575 0.96 0.67 1.36 0.80 
rs4681443 G 574 1. 11 0.83 1.46 0.48 
rs4681444 A 575 1.53 0.90 1.72 0.18 
rs1492103 G 575 0.94 0.66 1.33 0.71 
rs1492100 T 574 1.00 0.75 1.33 0.98 
rs3772616 C 574 1.20 0.85 1.48 0.42 
rs4524238 G 574 0.99 0.72 1.36 0.94 
rs12695891 A 569 0.70 0.400 1.23 0.22 
rsI2721328 G 575 0.82 0.45 1.48 0.51 
rs1826361 C 575 0.88 0.67 1.16 0.36 
rs12695902 G 575 1.61 0.92 2.80 0.09 
rs12721234 T 565 1.25 0.61 2.56 0.54 
rs12695918 C 575 1.03 0.71 1.49 0.88 
rs1800766 C 575 0.85 0.56 1.29 0.44 
rs12695923 C 574 0.96 0.71 1.30 0.80 
a Adjusted for age, gender, BMI, alcohol consumption, hypertension, hypertension 
medication and ~rinci~al com~onents. 
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Table 3-a. Unadjusted associations of AGT polymorphisms with difference in blood 
pressure (mean daytime - mean nighttime blood pressure). 







Allele (~) error 
C 703 0.64 1.17 
A 703 1.06 0.85 
C 703 0.64 1.08 
G 702 -0.54 0.61 
A 702 -0.40 0.66 





















Table 3-b. Unadjusted associations of ACE polymorphisms with difference in blood 
pressure (mean daytime - mean nighttime blood pressure). 
SNP Effect Allele N Beta (~) Standard error 
rs4297 C 701 -1.14 0.76 
rs12709426 G 697 -0.47 0.89 
rs4329 G 703 -0.17 0.43 


























Table 3-c. Unadjusted associations of AGTRl polymorphisms with difference in 
blood ~ressure {mean dal::time - mean nighttime blood ~ressure}. 
SNP Effect N Beta (p) Standard 95%CI P-value 
Allele error 
rs275651 A 688 -0.66 0.49 -1.62 0.30 0.18 
rs275652 G 702 -0.77 0.50 -1.74 0.20 0.12 
rs12721267 G 703 0.82 1.04 -1.24 2.87 0.43 
rs2933249 A 703 0.25 0.95 -1.61 2.12 0.79 
rs12721286 T 700 0.76 0.84 -0.89 2.41 0.37 
rs12721221 C 695 -0.45 0.53 -1.50 0.60 0.40 
rs2131127 G 702 -0.51 0.46 -1.41 0.39 0.27 
rs12695877 T 702 -0.47 0.45 -1.36 0.41 0.29 
rs4681440 C 703 -0.42 0.47 -1.34 0.51 0.38 
rs12721255 T 703 0.06 0.51 -1.06 0.94 0.91 
rs4681443 G 702 -0.63 0.44 -1.5 0.24 0.16 
rs4681444 A 703 -0.44 0.47 -1.37 0.48 0.35 
rs1492103 G 703 0.21 0.52 -0.80 1.22 0.69 
rs1492100 T 702 -0.25 0.46 -1.16 0.64 0.57 
rs3772616 C 702 0.11 0.44 -0.97 0.74 0.78 
rs4524238 G 702 0.09 0.49 -0.87 1.04 0.86 
rs12695891 A 696 -0.79 0.93 -2.62 1.04 0.40 
rs12721328 G 703 0.13 1.02 -1.87 2.14 0.90 
rs1826361 C 703 -0.71 0.43 -1.56 0.14 0.10 
rs12695902 G 703 0.30 0.80 -1.27 1.87 0.70 
rs12721234 T 691 -1.17 1.04 -3.20 0.87 0.26 
rs12695918 C 703 0.21 0.60 -0.97 1.38 0.73 
rs1800766 C 703 0.02 0.70 -1.38 1.34 0.98 
rs12695923 C 702 -0.37 0.47 -1.29 0.55 0.43 
Table 3-d. Adjusted model on the associations of AGT polymorphisms with difference 
in blood pressure (mean dal::time - mean nighttime blood pressure). 
SNP Effect Allele N Beta m Standard error 95% CI 
rs1926723 C 645 -0.36 1.14 -2.60 1.80 
rs2493129 A 645 0.89 0.89 -0.85 2.65 
rs11122576 C 645 0.18 1.16 -2.09 2.45 
rs11568026 G 645 -0.56 0.65 -1.84 0.72 
rsl1122577 A 644 -0.05 0.72 -1.45 1.36 
rsll122578 A 645 -0.18 1.16 -2.09 2.45 
P-valuea 
0.75 





a Adjusted for age, gender, BMI, alcohol consumption, mean systolic blood pressure, 
hypertension, h)'pertension medication and ~rincipal components. 
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Table 3-e. Adjusted model on the associations of ACE polymorphisms with 
difference in blood pressure (mean daytime - mean nighttime blood pressure). 
SNP Effect Allele N Beta (p) Standard error 95%CI P-value8 
rs4297 C 644 -0.80 0.81 -2.39 0.79 0.32 
rs12709426 G 645 -0.17 0.95 -2.02 1.69 0.86 
rs4329 G 644 .015 0.46 -1.05 0.75 0.75 
rs4324 G 643 -0.14 0.46 -1.05 0.76 0.75 
rs4325 A 644 -0.30 0.67 -1.62 1.03 0.66 
rs4351 G 638 0.04 0.46 -0.85 0.94 0.92 
a Adjusted for age, gender, BMI, alcohol consumption, mean systolic blood pressure, 
hn~ertension, hypertension medication and ~rinci~al com~onents. 
Table 3-f. Adjusted model on the associations of AGTRl polymorphisms with difference 
in blood ~ressure {mean daytime - mean nighttime blood ~ressure}. 
SNP Effect Allele N Beta (p) Standard error 95%CI P-vaIue8 
rs275651 A 631 -0.76 0.52 -1.78 0.26 0.14 
rs275652 G 645 -0.86 0.52 -1.88 0.17 0.10 
rs12721267 G 645 0.90 1.12 -1.29 3.10 0.42 
rs2933249 A 645 0.44 1.04 -1.60 2.48 0.67 
rs12721286 T 642 0.68 0.87 -1.04 2.29 0.44 
rs12721221 C 638 -0.71 0.60 -1.89 0.48 0.24 
rs2131127 G 644 -0.54 0.50 -1.51 0.43 0.28 
rsl2695877 T 644 -0.64 0.49 -1.61 0.32 0.19 
rs4681440 C 645 0.27 0.53 -1.31 0.77 0.61 
rs12721255 T 645 -0.41 0.60 -1.61 0.78 0.50 
rs4681443 G 644 0.80 0.48 -1.75 0.14 0.10 
rs4681444 A 645 -0.45 0.53 -1.49 0.59 0.40 
rs1492103 G 645 -0.30 0.61 -1.50 0.92 0.63 
rs1492100 T 644 -0.30 0.49 -1.26 0.66 0.54 
rs3772616 C 644 -0.27 0.47 -1 .20 0.66 0.57 
rs4524238 G 644 -0.03 0.54 -1.09 1.03 0.96 
rs12695891 A 639 0.90 0.98 -2.82 1.03 0.36 
rs12721328 G 645 0.86 1.14 -1.38 3.10 0.45 
rs1826361 C 645 -0.94 0.46 -1.85 -0.03 0.04 
rs12695902 G 645 0.30 0.87 0.73 -1.42 2.02 
rs12721234 T 633 -1.52 1.10 -3.68 0.64 0.17 
rs12695918 C 645 -0.02 0.64 1.27 1.24 0.98 
rsl800766 C 645 0.32 0.75 -1.16 1.79 0.67 
rs12695923 C 644 -0.44 0.50 -1.43 0.55 0.70 
a Adjusted for age, gender, BMI, alcohol consumption, mean systolic blood pressure, 
hypertension, hypertension medication and principal components. 
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Table 4-a. Linkage diseqeuilibrium-tagging SNPs inAGT. 
SNP Effect Allele Position 
rs1926723 C 228906719 
rs2493129 A 228907565 
rsll122576 C 228913302 
rs11568026 G 228914146 
rsll122577 A 228914179 
rsll122578 A 228914412 
*EAF = Effect Allele Frequency. Effect a1lele= minor allele. 
Table 4-b. Linkage disequilibrium-tagging SNPs in ACE. 
SNP Effect Allele Position 
rs4297 C 58910286 
rs12709426 G 58915488 
rs4324 G 58916903 
rs4325 A 58916932 
rs4329 G 58917190 
rs4351 G 58923464 






























Table 4-c. Linkage dise~uilibrium-tagging SNPs in AGTRJ. 
SNP Effect Allele Position EAF8 Function 
rs409742 G 149895055 0.234 5' near gene 
rs275651 A 149897577 0.15 5' near gene 
rs27S6S2 G 149897674 0.269 5' near gene 
rs12721267 G 149899017 0.246 Intron 
rs2933249 A 149899210 0.046 Intron 
rs12721286 T 149901605 0.072 Intron 
rs12721221 C 149902287 0.187 Intron 
rs2131127 G 149906833 0.316 Intron 
rs12695877 T 149909724 0.342 Intron 
rs4681440 C 149914722 0.238 Intron 
rs127212SS T 149914903 0.189 Intron 
rs4681443 G 149915159 0.375 Intron 
rs4681444 A 149915264 0.224 Intron 
rs1492103 G 149915654 0.16 Intron 
rs1492100 T 149920117 0.298 Intron 
rs3772616 C 149920881 0.328 Intron 
rs4524238 G 149922478 0.224 Intron 
rs12695891 A 149923336 0.058 Intron 
rsI2721328 G 149925644 0.046 Intron 
rs1826361 C 149927418 0.441 Intron 
rs12695902 G 149931108 0.082 Intron 
rs12721234 T 149938624 0.048 Intron 
rs12695918 C 149939317 0.153 Intron 
rs1800766 C 149940332 0.107 Intron 
rs1269S923 C 149940600 0.268 Intron 
*EAF = Effect Allele Frequency. Effect allele= minor aDele. 
47 
REFERENCES 
1. Mathews, T.J., et aL, Annual summary of vital statistics: 2008. Pediatrics, 2011. 127(1): 
p.146-57. 
2. Jolly,S., et aL, Higher Cardiovascular Disease Prevalence and Mortality among Younger 
Blacks Compared to Whites. The American journal of medicine, 2010.123(9): p. 811-
818. 
3. Elliott, W.J., The economic impact of hypertension. Journal of clinical hypertension, 
2003. 5(3 Suppl 2): p. 3-13. 
4. Miller, G., P. Hughes-Cromwick, and C. Roehrig, National spending on cardiovascular 
disease, 1996-2008. Journal of the American College of Cardiology, 2011. 58(19): p. 
2017-9. 
5. Heidenreich, P.A., et aL, Forecasting the Future of Cardiovascular Disease in the United 
States. Circulation, 2011. 
6. Pleis, J.R., B.W. Ward, and J.W. Lucas, Summary health statistics for u.s. adults: National 
Health Interview Survey, 2009. Vital and health statistics. Series 10, Data from the 
National Health Survey, 2010(249): p. 1-207. 
7. Ong, K.L., et aL, Prevalence, awareness, treatment, and control of hypertension among 
United States adults 1999-2004. Hypertension, 2007. 49(1): p. 69-75. 
8. Onusko, E., Diagnosing secondary hypertension. American family physician, 2003. 67(1): 
p.67-74. 
9. Keenan, N.L. and K.A. Rosendorf, Prevalence of hypertension and controlled 
hypertension - United States, 2005-2008. MMWR. Surveillance summaries: Morbidity 
and mortality weekly report. Surveillance summaries / CDC, 2011. 60 Suppl: p. 94-7. 
10. Schiller, J.S., et aL, Summary health statistics for u.s. adults: National Health Interview 
Survey, 2010. Vital and health statistics. Series 10, Data from the National Health Survey, 
2012(252): p. 1-207. 
11. Sherwood, A., et aL, Nighttime blood pressure dipping: the role of the sympathetic 
nervous system. American journal of hypertension, 2002. 15(2 Pt 1): p. 111-8. 
12. Paul, M., A. Poyan Mehr, and R. Kreutz, Physiology of local renin-angiotensin systems. 
Physiological reviews, 2006. 86(3): p. 747-803. 
13. Dickson, M.E. and C.D. Sigmund, Genetic Basis of Hypertension. Hypertension, 2006. 
48(1): p. 14-20. 
14. Atlas, S.A., The renin-angiotensin aldosterone system: pathophysiological role and 
pharmacologic inhibition. Journal of managed care pharmacy: JMCP, 2007. 13(8 Suppl 
B): p. 9-20. 
15. Rossier, B.C., Hypertension finds a new rhythm. Nature medicine, 2010. 16(1): p. 27-8. 
16. Vardeny, 0., et aL, beta2 adrenergic receptor polymorphisms and nocturnal blood 
pressure dipping status in the Wisconsin Sleep Cohort Study. Journal of the American 
Society of Hypertension: JASH, 2011. 5(2): p. 114-22. 
48 
17. Sherwood, A., et aI., Blood pressure dipping: ethnicity, sleep quality, and sympathetic 
nervous system activity. American journal of hypertension, 2011. 24(9): p. 982-8. 
18. Rotimi, c., et aI., Polymorph isms of Renin-Angiotensin Genes Among Nigerians, 
Jamaicans, and African Americans. Hypertension, 1996. 27(3): p. 558-563. 
19. Goldenberg, I., et aI., Polymorphism in the angiotensinogen gene, hypertension, and 
ethnic differences in the risk of recurrent coronary events. Hypertension, 2006. 48(4): p. 
693-9. 
20. Giner, V., et aI., Renin-angiotensin system genetic polymorphisms and salt sensitivity in 
essential hypertension. Hypertension, 2000. 35(1 Pt 2): p. 512-7. 
21. Jeunemaitre, X., et aI., Genetic polymorphisms of the renin-angiotensin system and 
angiographic extent and severity of coranary artery disease: the CORGENE study. Human 
genetics, 1997.99(1): p. 66-73. 
22. Goldenberg, I., et aI., Polymorphism in the Angiotensinogen Gene, Hypertension, and 
Ethnic Differences in the Risk of Recurrent Coronary Events. Hypertension, 2006. 48(4): 
p.693-699. 
23. Kunz, R., et aI., Association Between the Angiotensinogen 235T-Variant and Essential 
Hypertension in Whites: A Systematic Review and Methodological Appraisal. 
Hypertension, 1997.30(6): p. 1331-1337. 
24. Martinez-Rodriguez, N., et aI., Association of angiotensin /I type 1-receptor gene 
polymorphisms with the risk of developing hypertension in Mexican individuals. Journal 
of the renin-angiotensin-aldosterone system: JRAAS, 2011. 
25. Niu, W. and Y. Qi, Association of the angiotensin II type I receptor gene +1166A>C 
polymorphism with hypertension risk: evidence from a meta-analysis of 16474 subjects. 
Hypertension research: official journal of the Japanese Society of Hypertension, 2010. 
33(11): p. 1137-43. 
26. O'Donnell, C.J., et aI., Evidence for association and genetic linkage of the angiotensin-
converting enzyme locus with hypertension and blood pressure in men but not women in 
the Framingham Heart Study. Circulation, 1998.97(18): p. 1766-72. 
27. Cooper, R., et aI., The prevalence of hypertension in seven populations of west African 
origin. American journal of public health, 1997.87(2): p. 160-8. 
28. Adeyemo, A., et aI., A genome-wide association study of hypertension and blood 
pressure in African Americans. PLoS genetics, 2009. 5(7): p. el000564. 
29. Profant, J. and J.E. Dimsdale, Race and diurnal blood pressure patterns. A review and 
meta-analysis. Hypertension, 1999. 33(5): p. 1099-104. 
30. Wang, X., et aI., Genetic influences on heart rate variability at rest and during stress. 
Psychophysiology, 2009.46(3): p. 458-65. 
31. Bristow, M.R., 6-Adrenergic Receptor Blockade in Chronic Heart Failure. Circulation, 
2000. 101(5): p. 558-569. 
32. Julve, R., et aI., Polymorphism insertion/deletion of the ACE gene and ambulatory blood 
pressure circadian variability in essential hypertension. Blood pressure monitoring, 2001. 
6(1): p. 27-32. 
49 
33. Jian, M., et aL, Polymorphism of angiotensin I converting enzyme gene in the older 
Chinese: linked to ambulatory blood pressure levels and circadian blood pressure 
rhythm. International Journal of Cardiology, 1996. 55(1): p. 33-40. 
34. Kario, K., et aL, Angiotensinogen and angiotensin-converting enzyme genotypes, and day 
and night blood pressures in elderly Japanese hypertensives. Hypertension research: 
official journal of the Japanese Society of Hypertension, 1999.22(2): p. 95-103. 
35. Hickson, D.A., et aL, Socioeconomic position is positively associated with blood pressure 
dipping among African-American adults: the Jackson Heart StUdy. American journal of 
hypertension, 2011. 24(9): p. 1015-21. 
36. Barksdale, D.J., C. Woods-Giscombe, and J.G. Logan, Stress, Cortisol, and Nighttime 
Blood Pressure Dipping in Nonhypertensive Black American Women. Biological Research 
For Nursing, 2012. 
37. Tomfohr, L., et aL, Everyday discrimination and nocturnal blood pressure dipping in black 
and white americans. Psychosomatic medicine, 2010. 72(3): p. 266-72. 
38. Mellman, T.A., et aL, Posttraumatic stress disorder and nocturnal blood pressure dipping 
in young adult African Americans. Psychosomatic medicine, 2009. 71(6): p. 627-30. 
39. Bureau, U.S.c., The American Commuity- Blacks: 2004. 2007. 
40. The 2005 Mississippi State of the Heart Report, M.D.o. Health, 
O.o.P.H.a.O.o.H.S.D.U.a.t.A. Heart, and Association, Editors. 2005. 
41. Wyatt, S.B., et aL, Prevalence, awareness, treatment, and control of hypertension in the 
Jackson Heart Study. Hypertension, 2008. 51(3): p. 650-6. 
42. Fuqua, S.R., et aL, Recruiting African-American research participation in the Jackson 
Heart Study: methods, response rates, and sample description. Ethnicity & disease, 2005. 
15(4 SuppI6): p. 56-18-29. 
43. Hickson, D.A., et aL, Geographic Representation of the Jackson Heart Study Cohort to the 
African-American Population in Jackson, MisSiSSippi. American journal of epidemiology, 
2010. 
44. Sachdeva, A. and A.B. Weder, Nocturnal sodium excretion, blood pressure dipping, and 
sodium sensitivity. Hypertension, 2006.48(4): p. 527-33. 
45. Barrett, J.c., et aL, Haploview: analysiS and visualization of LD and haplotype maps. 
Bioinformatics, 2005. 21(2): p. 263-265. 
46. Johnson, A.D., et aL, SNAP: a web-based tool for identification and annotation of proxy 
SNPs using HapMap. Bioinformatics, 2008. 24(24): p. 2938-2939. 
47. Hindorff, L.A., et aL, Potential etiologiC and functional implications of genome-wide 
association loci for human diseases and traits. Proceedings of the National Academy of 
Sciences, 2009.106(23): p. 9362-9367. 
48. Lewis, C.M. and J. Knight, Introduction to Genetic Association Studies. Cold Spring Harbor 
Protocols, 2012. 2012(3): p. pdb.top068163. 
50 
CURRICULUM VITAE 
NAME: Jersy L. Napoleon 
ADDRESS: University of Louisville 
School of Public Health and Information Sciences 
485 E. Gray Street 
Louisville, KY 40202 




Bachelor of Arts in Biology. Berea College, Berea, Kentucky, May 2007. 
Bachelor of Arts in Spanish. Berea College, Berea, Kentucky, May 2007. 
Thesis Research: "Genetic variation in the renin-angiotensin system: 
associations with blood pressure dipping in the Jackson Heart Study, " 
University of Louisville, Louisville, KY. 
November 201 I-August 2012 
Governor's Internship, Indiana State Health Department, Indianapolis, IN. 
Interned with the Tobacco Prevention and Cessation Commission (TPC). 
May-July 2011 
Kentucky Biomedical Research Infrastructure Network (KBRIN) 
University of Kentucky. Lexington, KY. 
Summer 2005 
Kentucky Biomedical Research Infrastructure Network (KBRIN) 
Berea College. Berea, KY. 
Summer 2004 
Father Henry L. Parker Scholarship, for high academic achievement and 
ethnic pride. 
Berea College, Berea, KY. 
Spring 2005 
51 
